Dindolyl Methane, or DIM as it is commonly referred to, is a well-known supplement for bodybuilders as well as other individuals interested in enhancing the growth of their muscles. Recent studies have revealed that DIM could pose health hazards. DIM can cause liver damage when taken in excess. Another risk is kidney damage, which can lead to kidney failure. The potential long-term health risks associated with DIM make many athletes and bodybuilders ask the question: should I use an supplement with DIM?
The majority of people take diindolylmethane supplements to boost the production of testosterone. Testosterone is known to act as an androgen, which means that it can cause hormonal changes in tissues. DIM has been demonstrated in studies to mimic the effects of testosterone, as well as other hormones. Some manufacturers have added diindolylmethane (DIM) to their products to boost their marketability in male circles since men are more likely to produce testosterone than women do. Men will react to products that mimic natural testosterone.
Many companies advertise DIM as a tumor-suppressor. It’s true that diindolylmethane does reduce the growth of tumors in laboratory animals, but the animals were administered the drug, not taken orally. In order for humans to experience the same effect diindolylmethane has to be administered in large doses over an extended period of time. In addition, while the animals tested were cancer-free for a number of years but all of them had liver problems at some point, possibly due to too much diindolylmethane being present in their bodies. To get a real glimpse of how DIM works in the body, you should seek out a medical professional.
The only way to prove that DIM is effective in treating breast carcinoma is to do an experiment in which cells from healthy breast cells are exposed to high doses of diindolylmethane for an extended period of time. There are pros and negatives to using DIM as with any chemical. The advantages include the capability to mimic hormones. This means that you could make insulin, which could reduce the proliferation of cancerous cells. The downside is that diindolylmethane produces a harmful chemical known as DMSO. Read more about dim (diindolylmethane) here.
One of the most popular claims made for diindolylmethane as treatment for different health issues is that it can act as a natural, anti-fungal, antibacterial and anti-cancer agent. The National Institute of Health, through a thorough study of supporting data, concluded that there was no basis for these claims. According to the Institute of Chemical Technology there were no experiments which supported this assertion. The Institute of Chemical Safety, conducting an in-depth study of the safety profile of the firestone concluded that the information presented by pharmaceutical companies about the benefits of diindolylmethane for humans were not completely reliable.
Van der Goes and. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. pointed out numerous potential hazards related to diindolylmethane’s use, such as skin rash, allergic reactions, asthma attacks, dizziness, headaches, and respiratory problems. The recommended daily allowance for this chemical, which is about one tenth to a teaspoon is 0.2 milligrams. It is not known how much concentration it will have when this chemical is mixed with other compounds. Since this substance hasn’t been thoroughly tested, it cannot be considered to be safe at any level.
The abstract of the view indicates that the use of diindolylmethane (DIEM) in the treatment of cancer is based on the idea of inhibiting intracellular inhibition of pyruvate metabolite through flavenoids, thereby stopping the accumulation of oxalates within renal tubule cells as well as adenine granulocyte cultures. However, the metabiplicate drug toxicity studies did not present convincing evidence that consumption of this chemical results in an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the company that manufactures firestone Tincture is in the process of completing two major tests in Europe and the United States.
The abstract of the view also reveals that the use of diindolylmethane (DIEM) in the treatment of cancer is based on the principal of blocking intracellular inhibition of pyruvate metabolite through flavenoids, thus preventing accumulation of oxalates in renal tubule cells and adenine granulocyte cultures. Metabiplicate toxicology studies on the drug have not proven that this chemical can cause overdose. The Food and Drug Administration approved the substance as a prescription drug in June 1996. According to the FDA, the manufacturer of firestone tincture is currently in the process of completing two major trials–one in Europe and one in the United States. According to the FDA the company that produces firestone tincture is in the process of finishing two major trials in Europe and one in the United States.